Beatson International Cancer Conference - Cancer: from Pedigree to Protein
1998
Cancer: from Pedigree to Protein
Sample size: 27
publication
Evidence: moderate
Author Information
Author(s): VG Brunton, N Keith
Primary Institution: Beatson Institute for Cancer Research
Hypothesis
What percentage of human tumours are truly immortal and have escaped senescence?
Conclusion
The meeting highlighted the importance of understanding genetic and cellular mechanisms in developing new cancer therapies.
Supporting Evidence
- The study of BRCA1 provides a perfect example of how cancer research spans from pedigree to protein.
- A phase 1 trial using an adenovirus targeted to mutant p53 in patients with squamous cell carcinoma showed limited toxicities.
- The reactivation of telomerase in cancer cells has taken on a central role in tumour development.
Takeaway
Scientists are learning how cancer cells work so they can create better treatments, and they are using information from genes to help with this.
Methodology
The meeting included discussions on various genetic and cellular studies related to cancer.
Limitations
The exact mechanisms of some treatments, like BRCA1 gene therapy, are not fully understood.
Want to read the original?
Access the complete publication on the publisher's website